Phase I Clinical Study to Evaluate Safety and Efficacy of ANT-301 in Knee Osteoarthritis Patients
Latest Information Update: 17 Dec 2024
At a glance
- Drugs Adipose stem cell therapy Anterogen (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions
- Sponsors Anterogen
Most Recent Events
- 13 Dec 2024 Planned End Date changed from 1 Aug 2025 to 1 Jul 2026.
- 13 Dec 2024 Status changed from not yet recruiting to recruiting.
- 09 Aug 2024 New trial record